Edwards Lifesciences Corporation (EW) Balance Sheet
As of 2026-06-30 (10-Q), Edwards Lifesciences Corporation (EW) reported total assets of $13.9B, total liabilities of $3.1B and shareholders' equity of $10.6B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $2.9B. Long-term debt: $598.7M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
EWEdwards Lifesciences CorporationFollow EW — free
—
Price chart with a free account
- Market cap
- 51.3B
- P/E TTM
- 51.2
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.40 | 0.17 | 0.31 | 0.42 | 0.65 | 0.72 | 0.93 | 0.82 | 0.71 | 1.18 | 1.18 | 0.86 | 0.77 | 1.13 | 3.05 | 2.94 | 2.91 | |
| Short-term investments | — | 0.28 | 0.21 | 0.52 | 0.79 | 0.51 | 0.34 | 0.52 | 0.24 | 0.34 | 0.22 | 0.60 | 0.45 | 0.50 | 0.93 | 1.29 | 1.35 | |
| Receivables | 0.28 | 0.28 | 0.32 | 0.30 | 0.29 | 0.32 | 0.37 | 0.44 | 0.46 | 0.54 | 0.51 | 0.58 | 0.64 | 0.77 | 0.61 | 0.66 | 0.77 | |
| Inventory | 0.20 | 0.26 | 0.28 | 0.31 | 0.30 | 0.34 | 0.40 | 0.55 | 0.61 | 0.64 | 0.80 | 0.73 | 0.88 | 0.90 | 1.09 | 1.13 | 1.13 | |
| Current assets | 1.03 | 1.17 | 1.29 | 1.73 | 2.23 | 2.05 | 2.24 | 2.55 | 2.29 | 2.98 | 3.09 | 3.18 | 3.10 | 4.04 | 6.29 | 6.74 | 6.82 | |
| Total assets | 1.77 | 1.98 | 2.22 | 2.71 | 3.52 | 4.06 | 4.51 | 5.67 | 5.32 | 6.49 | 7.24 | 8.50 | 8.29 | 9.36 | 13.06 | 13.70 | 13.87 | |
| Current liabilities | 0.34 | 0.34 | 0.35 | 0.35 | 0.43 | 0.48 | 0.53 | 1.42 | 0.88 | 0.90 | 0.89 | 1.03 | 1.02 | 1.20 | 1.51 | 1.81 | 1.51 | |
| Long-term debt | — | — | 0.19 | 0.59 | 0.60 | 0.60 | 0.82 | 0.44 | 0.59 | 0.59 | 0.60 | 0.60 | 0.60 | 0.60 | 0.60 | 0.60 | 0.60 | |
| Short-term debt | — | — | — | — | — | — | 0.00 | 0.60 | 0.00 | — | — | — | — | — | — | — | — | |
| Total liabilities | — | — | — | — | — | — | — | — | — | — | 2.66 | 2.67 | 2.49 | 2.64 | 2.99 | 3.36 | 3.14 | |
| Shareholders' equity | 1.31 | 1.33 | 1.47 | 1.54 | 2.19 | 2.50 | 2.62 | 2.96 | 3.14 | 4.15 | 4.57 | 5.84 | 5.81 | 6.65 | 10.00 | 10.34 | 10.62 |
USD billions · SEC XBRL
Edwards Lifesciences Corporation — questions
- How much cash does Edwards Lifesciences Corporation have?
- $2.9B in cash and cash equivalents as of 2026-06-30.
- How much debt does Edwards Lifesciences Corporation have?
- $598.7M of long-term debt as of 2026-06-30.
- What are Edwards Lifesciences Corporation's total assets?
- $13.9B as of 2026-06-30.
- What is Edwards Lifesciences Corporation's shareholders' equity?
- $10.6B as of 2026-06-30.
Every figure on this page comes from Edwards Lifesciences Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.